Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
John E Gallina is Director at Arrive AI. OQRO lists 6 transactions filed with the SEC under this name, the latest on Oct 9, 2026, each linked to the official Form 4.
Director
Disclosures on record
6
Companies involved
2
Arrive AIARAI
4 disclosures · Jan 2026 – Oct 2026
Oct 2, 2026173Kdisclosed Oct 9
DetailsOfficial recordJul 6, 202687Kdisclosed Jul 7
DetailsOfficial recordMar 31, 202647Kdisclosed Apr 2
DetailsOfficial recordDec 31, 202514Kdisclosed Jan 5
DetailsOfficial recordCVS HealthCVS
2 disclosures · Mar 2026 – May 2026
May 14, 20261,447.5disclosed May 15
DetailsOfficial recordMar 19, 2026582disclosed Mar 20
DetailsOfficial recordJohn E Gallina has no open-market purchase on record since 2012. Sales in 6 of the 15 years since 2012.
John E Gallina reported 0 open-market purchases and 16 sales since 2012; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2021 | — | $18.3M5×5 trades |
| 2018 | — | $5.65M3×3 trades |
| 2015 | — | $5.75M4×4 trades |
| 2014 | — | $1.59M1×1 trade |
| 2013 | — | $4.8M1×1 trade |
| 2012 | — | $1.76M2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
As of the latest filing on , John E Gallina reported holding 582 shares of CVS Health (CVS), worth about $52K at the last close of $89 (Nov 16, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| CVS Health CVS | 582 | 582 direct | $89 | $52K | Mar 19, 2026 |
Is this John E Gallina’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Mar 19, 2026, John E Gallina reported holding 582 shares of CVS Health (CVS). At the last close of $89 on Nov 16, 2026, that is about $52K. This is the stake disclosed in filings, not a net worth.
John E Gallina has no open-market purchase on record since 2012. Sales in 6 of the 15 years since 2012.
In SEC filings since 2012: no open-market purchase is on record; the latest open-market sale is from 2021.
Elevance Health (ELV), from 2012 to 2021: 0 purchases and 16 sales.
John E Gallina reported 0 open-market purchases and 16 sales here, 2012 to 2021.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.